State VA
Clinical Trials in Virginia
Recruiting clinical trials with at least one study location in Virginia. Data updated daily from ClinicalTrials.gov.
Top Conditions in Virginia
NCT05915299 N/A
Recruiting
US National OCS Heart Perfusion (OHP) Registry
Condition
Heart Transplant
Enrollment
100,000 pts
Location
United States
Sponsor
TransMedics
NCT04862468 Phase 2
Recruiting
Perivenous Dexamethasone Therapy: Examining Reduction of Inflammation After Thro...
Condition
Thrombosis, Deep Vein
Enrollment
80 pts
Location
United States, Ireland, United Kingdom
Sponsor
Mercator MedSystems, Inc.
NCT05983250 Phase 3
Recruiting
LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF
Condition
Pulmonary Hypertension
Enrollment
230 pts
Location
United States, Canada
Sponsor
Tenax Therapeutics, Inc.
NCT06118281 Phase 3
Recruiting
ARTEMIS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo...
Condition
Cardiovascular Risk
Enrollment
10,000 pts
Location
United States, Argentina, Australia
Sponsor
Novo Nordisk A/S
NCT00231400 N/A
Recruiting
Pompe Disease Registry Protocol
Condition
Glycogen Storage Disease Type II
Enrollment
2,000 pts
Location
United States, Argentina, Australia
Sponsor
Genzyme, a Sanofi Company
NCT05912517 Phase 3
Recruiting
A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of th...
Condition
Hemolytic Disease of the Fetus and Newborn
Enrollment
120 pts
Location
United States, Argentina, Australia
Sponsor
Janssen Research & Development
NCT05673148 Phase 3
Recruiting
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatme...
Condition
Metastatic Colorectal Adenocarcinoma
Enrollment
364 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT06014658 Phase 1, Phase 2
Recruiting
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tu...
Condition
Cancer
Enrollment
130 pts
Location
United States
Sponsor
MBrace Therapeutics
NCT06692738 Phase 3
Recruiting
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for...
Condition
Non-small Cell Lung Cancer
Enrollment
880 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT04988555 Phase 1, Phase 2
Recruiting
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horiz...
Condition
Leukemia, Myeloid, Acute
Enrollment
606 pts
Location
United States, Belgium, Canada
Sponsor
Sumitomo Pharma America, Inc.
NCT06942949 N/A
Recruiting
Evaluation of Enhanced Lithotripsy System (ELS) in the Treatment of Urinary Ston...
Condition
Kidney Calculi; Ureteral Calculi
Enrollment
101 pts
Location
United States
Sponsor
Avvio Medical
NCT06052267 Phase 3
Recruiting
A Study to Test if a Fixed-Dose Combination of Fluticasone Propionate/Albuterol ...
Condition
Asthma
Enrollment
2,700 pts
Location
United States, Argentina, Australia
Sponsor
Teva Branded Pharmaceutical Pr
NCT07002034 Phase 2
Recruiting
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medic...
Condition
Adjustment Disorder
Enrollment
100 pts
Location
United States
Sponsor
Reunion Neuroscience Inc
NCT06038240 N/A
Recruiting
Optimizing Pain Self-Management in Total Knee Arthroplasty
Condition
Osteo Arthritis Knee
Enrollment
150 pts
Location
United States
Sponsor
University of Virginia
NCT06543576 Phase 1, Phase 2
Recruiting
External Beam Radiation Therapy and Brachytherapy With Chemotherapy and Immunoth...
Condition
Cervical Adenocarcinoma
Enrollment
35 pts
Location
United States
Sponsor
Jonsson Comprehensive Cancer C
NCT06393374 Phase 3
Recruiting
Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did ...
Condition
Triple-Negative Breast Cancer
Enrollment
1,530 pts
Location
United States, Argentina, Australia
Sponsor
Merck Sharp & Dohme LLC
NCT06108050 Phase 1
Recruiting
JZP898 Intravenous Infusion as Monotherapy and Combination With Pembrolizumab in...
Condition
Advanced Solid Tumor
Enrollment
177 pts
Location
United States
Sponsor
Jazz Pharmaceuticals
NCT06794996 Phase 2
Recruiting
Inaxaplin in Participants With Proteinuric APOL1 Mediated Kidney Disease With or...
Condition
Proteinuric Kidney Disease
Enrollment
45 pts
Location
United States
Sponsor
Vertex Pharmaceuticals Incorpo
NCT06688825 N/A
Recruiting
Feasibility Study for the Comprehensive Overweight/Obesity Management Pre-Kidney...
Condition
Kidney Transplant; Complications
Enrollment
30 pts
Location
United States
Sponsor
Virginia Commonwealth Universi
NCT07130695 Phase 1
Recruiting
Olutasidenib Single Plus Combo Therapy in IDH1mut AML After Induction and Consol...
Condition
Acute Myeloid Leukemia
Enrollment
15 pts
Location
United States
Sponsor
Virginia Commonwealth Universi
NCT06785636 Phase 1, Phase 2
Recruiting
Open-Label Study of Pocenbrodib Alone and in Combination With Abiraterone Acetat...
Condition
mCRPC (Metastatic Castration-resistant Prostate Cancer)
Enrollment
252 pts
Location
United States
Sponsor
Pathos AI, Inc.
NCT06258109 N/A
Recruiting
Risk of Recurrent CeAD After Pregnancy
Condition
Cervical Artery Dissection
Enrollment
1,000 pts
Location
United States, Argentina, Austria
Sponsor
University Hospital, Basel, Sw
NCT07044336 Phase 3
Recruiting
Puxitatug Samrotecan (AZD8205) Monotherapy vs Chemotherapy in B7-H4-selected End...
Condition
Endometrial Cancer
Enrollment
700 pts
Location
United States, Argentina, Australia
Sponsor
AstraZeneca
NCT02701244 N/A
Recruiting
A Registry Study of Breast Microseed Treatment
Condition
Breast Neoplasms
Enrollment
420 pts
Location
United States
Sponsor
Concure Oncology-Breast Micros
NCT05983432 Phase 1
Recruiting
Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lun...
Condition
Non Small Cell Lung Cancer
Enrollment
470 pts
Location
United States, France, Italy
Sponsor
SystImmune Inc.